JDS DERMATO
ActiveSummary
JDS DERMATO has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €3k and a net result of €105k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 8% of 16546 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
68
/ 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency28▼-72
Growth58▼-20
Track record94
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit check for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
2.7%
Return on assets
94.3%
Age of the figures
9 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 8% of 16546 sector peers (2025).
NBB · sector comparisonPosition among 16546 sector peers
Solvency
better than 8%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-04-2026, 94 days ahead of the deadline.
NBB · 4 filingsDeviation from the deadline
2025
94 d early
2024
84 d early
2023
64 d early
2022
47 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€3k▼ 98.4%
2024 · €183k
2022: €7k
2023: €73k
2024: €183k
2022 → 2025
Total assets
€111k▼ 50.0%
2024 · €222k
2022: €15k
2023: €93k
2024: €222k
2022 → 2025
Net result
€105k▼ 5.5%
2024 · €111k
2022: €4k
2023: €65k
2024: €111k
2022 → 2025
Working capital
€-5k
2024 · €183k
2022: €5k
2023: €70k
2024: €183k
2022 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line2022202320242025Trend
Equity€7k-€73k▲ 918%€183k▲ 153%€3k▼ 98.4%
Operating result€6k-€84k▲ 1,396%€144k▲ 72.2%€136k▼ 5.6%
Net result€4k-€65k▲ 1,484%€111k▲ 69.2%€105k▼ 5.5%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 6% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €111k
Fixed assets
€10k ▲ 697%
Current assets
€101k ▼ 54.1%
Equity and liabilities €111k
Equity
€3k ▼ 98.4%
Debt
€108k ▲ 181%
Debt's share of the balance-sheet total rises from 17.3% to 97.3%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€137k▼
2024 · €145k
Cash flow
€106k▼
2024 · €112k
Current ratio
0.96▼
2024 · 5.86
Debt to equity
35.98▲
2024 · 0.21
ROA
94.3%▲
2024 · 49.9%
Interest coverage
955.50▼
2024 · 1839.71
Debt ≤ 1 year
€106k▲
2024 · €38k
Income taxes
€31k▼
2024 · €33k
A ratio outside any meaningful range has been withheld (balance sheet total €111k, equity €3k).
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 45 lines
Balance sheet
Code20242025
Assets
Total assets20/58€222k€111k▼
Fixed assets21/28€1k€10k▲
Tangible fixed assets22/27€1k€10k▲
Plant, machinery and equipment23€406€0▼
Furniture and vehicles24€801€233▼
Other tangible fixed assets26-€9k
Current assets29/58€221k€101k▼
Amounts receivable within one year40/41€75k€19k▼
Trade receivables40€75k€17k▼
Other amounts receivable41-€2k
Current investments50/53-€50k
Cash at bank and in hand54/58€146k€32k▼
Deferred charges and accrued income490/1€176€298▲
Equity and liabilities
Total equity and liabilities10/49€222k€111k▼
Equity10/15€183k€3k▼
Contributions10/11€3k€3k=
Reserves13€180k€0▼
Distributable reserves133€180k€0▼
Profit (loss) carried forward14-€0
Amounts payable17/49€38k€108k▲
Amounts payable within one year42/48€38k€106k▲
Trade debts44€788€1k▲
Suppliers440/4€788€1k▲
Taxes, remuneration and social security45€33k€16k▼
Taxes450/3€33k€16k▼
Other amounts payable47/48€4k€89k▲
Accrued charges and deferred income492/3€800€2k▲
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€2k€1k▼
Other operating charges640/8€302€745▲
Gross operating margin9900€146k€138k▼
Operating profit (loss)9901€144k€136k▼
Financial income75/76B-€0
Recurring financial income75-€0
Financial charges65/66B€79€143▲
Recurring financial charges65€79€143▲
Profit (loss) for the period before taxes9903€144k€136k▼
Income taxes67/77€33k€31k▼
Profit (loss) for the period9904€111k€105k▼
Profit (loss) for the period to be appropriated9905€111k€105k▼
Appropriation of the result
Profit (loss) to be appropriated9906€111k€105k▼
Transfer from equity791/2-€180k
Transfer to equity691/2€111k€0▼
To other reserves6921€111k€0▼
Profit to be distributed694/7-€285k
Return on contributions (dividend)694-€285k
The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
28-04
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
08-05
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Highest result since 2022net €111k ▲69.2%
Operating result €144k, net result €111k, both a record.
31-12
Financial
Equity above €150kEq €183k ▲153%
3 profitable years in a row build equity to €183k.
28-05
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Liquidity triplescurrent ratio 4.39
Current ratio from 1.64 to 4.39.
14-06
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Hasselt · 1 establishment unit since 2022
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Grote Roost 593500 HasseltGround area
1,575 m²
Building footprint
144 m²
Parcel 71052A0230/00H000, Flanders. Linked by address, not a title deed.
1 establishment unit
JDS DERMATO
since 20222.330.591.779
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 71052A0230/00H000 | Flanders | 1,575 m² | 1 · 144 m² | - |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Het Oogpunt
BE 0635.657.925
Roeselare · Eq €3,000
Oncologie Dr. WOLTER Pascal
BE 0650.849.313
Baelen · Eq €3,000
Dr CHULLIKAL
BE 0727.474.363
Grez-Doiceau · Eq €3,000
Docteur Déborah LAMBERT
BE 0738.476.143
Jalhay · Eq €3,000
DOKTER DE ROECK YENTL
BE 0739.739.024
Kontich · Eq €3,000
Of 16,627 companies in sector 86220 we hold annual accounts for 7,974. 1,153 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded31-03-2022
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
82100Office administrative and support services
82990Other business support services
Sources
Crossroads Bank for EnterprisesNational Bank · 4 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.